We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Recent research advances in the development of Dabie Banda virus vaccines.
- Authors
Yu, Chenyang; Lin, Yuxiang; Dai, Yixin; Wu, Bingan; Qi, Zhongtian; Qian, Xijing
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is a newly identified tick-borne viral hemorrhagic fever caused by Dabie Banda virus (DBV). The virus was first discovered in eastern China in 2009 and is now considered an infectious disease with a mortality rate ranging from 6.3% to 30%. The best strategy for controlling SFTS is to develop effective vaccines. However, no approved vaccines are currently available to prevent this disease, despite the number of extensive and in-depth studies conducted on DBV in the past few years. This review focuses on the structure of DBV and the induced host immune responses which are the fundamental factors in vaccine development, and thoroughly summarizes the current research progress on DBV vaccines. The developing DBV vaccines include protein subunit vaccines, live attenuated vaccines, recombinant virus vector vaccines, and DNA vaccines. At present, almost all candidate vaccines for DBV are in the laboratory development or preclinical stages. There remain challenges in successfully developing clinically approved DBV vaccines.
- Subjects
PEPTIDE vaccines; DNA vaccines; HEMORRHAGIC fever; VIRAL vaccines; VACCINE effectiveness
- Publication
PLoS Neglected Tropical Diseases, 2024, Vol 18, Issue 8, p1
- ISSN
1935-2727
- Publication type
Article
- DOI
10.1371/journal.pntd.0012411